Author: IeDEA

Investigators from Resource-Limited Settings and Early Stage Investigators from All Countries can apply for Travel Scholarships for the 21st International Workshop on Co-morbidities and Adverse Drug Reactions in Basel, Switzerland from 5–6 November 2019

Applications for the scholarship are due on Thursday 11th July 2019 by 12 midnight UK time and they cover the following:

1. Free registration to the Comorbidities Workshop (5-6 November) and free registration to the European AIDS Conference (6-9 November)
2. Round-trip air travel to Basel, Switzerland (economy class)
3. Accommodation for up to 5 nights in total (to be allocated across both meetings)

The application form is available for download here and more information can be found here.

Continue reading “Travel Scholarships Available for the 2019 HIV Co-morbidity Workshop/EACS in Basel, Switzerland”

The International AIDS Society (IAS) is honoured to extend an invitation for participation in a scientific symposium fully endorsed by the Zimbabwean Ministry of Health and Child Care, under the theme, Translating Science to End HIV in Southern Africa. The symposium will take place at the Holiday Inn in Harare, Zimbabwe on 24th June 2019.

The symposium will feature leaders in the HIV response sharing how service providers and public health professionals in Southern Africa can best incorporate new science and approaches into their programmes and planning.

For more information and to register, please click here

The 17th European AIDS Conference will take place in Basel from November 6-9, 2019. International experts are brought together to share their science, expertise and experience. All healthcare professionals involved in the field of HIV and co-infections are encouraged to join at the upcoming Conference.

Abstract submission and early registration close on July 11, 2019.

For more information, visit the EACS website.

Prior to the 10th IAS Conference on HIV Science (IAS 2019) in Mexico City, Mexico this July there will be a series of pre-meetings providing an in-depth focus on key topics in advance of IAS 2019. Browse the list below and register to plan your pre-conference activities in Mexico City. Continue reading “IAS 2019 pre-meeting registration now open”

The 17th International Conference on Malignancies in HIV/AIDS will take place October 21-22, 2019, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland.

The meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.

Recent advances in areas such as viral oncology, immunology, genetics, epidemiology, pathogenesis, early diagnosis, and clinical investigation of malignant diseases associated with HIV and other acquired immunodeficiency states will be shared at this conference. Our objective is to facilitate the exchange of information between laboratory and clinical researchers so as to accelerate the translation of basic scientific discoveries into clinical applications.

For more information and to register, please visit the ICMH website

 

This year’s prestigious Swiss TB Award from the Swiss Foundation for Tuberculosis Research was awarded to Kathrin Zürcher and Dr Marie Ballif from the University of Bern IeDEA Southern Africa team.

The IeDEA-multi-regional study, published in Lancet Infectious Diseases, shows that inaccurate tests carried out on tuberculosis patients in developing countries often fail to reliably detect resistance to drugs, leading to incorrect treatment and a higher mortality rate. Continue reading “Swiss TB Award 2019 for IeDEA-SA Researchers”

The Journal of the International AIDS Society (JIAS) has opened a call for papers for a new special issue on “Data-driven HIV prevention: the HIV prevention cascade and beyond” to be published in conjunction with the 23rd International AIDS Conference (AIDS 2020).

Deadline for submission is July 15 and papers could include:

• Empirical papers reporting studies that collect, validate, analyse and/or use data to identify population HIV prevention needs, monitor prevention delivery, or evaluate programmatic approaches
• Papers that use data to operationalise “prevention cascade” frameworks or assess the strengths and limitations of alternative approaches to data driven HIV prevention
• Systematic reviews in relevant areas
• Cost-effectiveness studies on data-driven HIV prevention approaches or reports on the current state of financing for data-driven HIV prevention
• Modelling studies that extend current approaches to provide improved strategic information to guide HIV prevention programming
• Descriptions and evaluations of data systems that provide decision makers with relevant information to inform HIV prevention decisions
• Policy analyses in relation to data-driven HIV prevention

To find out more about this upcoming special issue and how you can submit your article, please click here